Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19.
Título
Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19.
Autor
Emilio Di Maria, Paolo Martini, Massimo Gennarelli
Fecha
2021
Identificador
10.1016/j.phrs.2020.105402
Fuente
Pharmacological research
Archivos
Colección
Citación
Emilio Di Maria, Paolo Martini, Massimo Gennarelli, “Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19.,” SOCICT Open, consulta 11 de junio de 2026, https://www.socictopen.socict.org/items/show/8425.
Position: 17224 (20 views)